Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Patients felt happier with their looks and younger after hair transplant surgery, but their well-being and social life didn't change much.

Patients with alopecia areata face treatment barriers due to lack of reimbursement and need more support and information.

Doctors must fully inform patients about hair transplant surgery to help them decide and reduce legal issues.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Patients are interested in anti-aging treatments but rely on dermatologists for guidance.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Patients chose Chinese herbal medicine for safety, relapse prevention, and as an alternative to conventional treatments, but found preparation burdensome.

Facebook groups play a crucial role in supporting and guiding patients on scalp cooling and hair loss during chemotherapy.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.

The document concludes that while some advocate for a patient voucher system, it may be unequal and current healthcare reforms should be given a chance, and it also recommends various medical books for their comprehensive coverage and advice on specific health issues.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Certain hair and scalp features can predict the severity of alopecia areata.

Accurate diagnosis and early specialist referral are crucial for managing 46,XY Disorders of Sex Development.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.